FDA clears Halyard ’ s Coolief RF device for treating OA pain
Halyard Health (NYSE:HYH) said today it won FDA clearance for its Coolief cooled radiofrequency thermal system designed for treating moderate to severe chronic osteoarthritis knee pain The Alpharetta, Ga.-based company claims that the Coolief is the 1st and only RF treatment to be cleared by the FDA for relieving OA pain. “I see many patients who suffer with chronic osteoarthritis knee pain in my practice who are not immediate candidates for knee replacement surgery due to co-morbidities, such as obesity or other chronic health issues. Coolief Cooled RF treatment provides significant pain relief for patients with OA of the knee until they are able to undergo surgery. Until now there have been few options available for my patients,” study investigator Dr. Timothy Davis of Orthopedic Pain Specialists said in a prepared statement. Clearance came based on results from a 151-patient prospective, randomized trial comparing the Coolief system to intra-articular steroid injections in patients suffering from OA knee pain. Results indicated that 74.1% of participants treated with the Coolief system reported pain reduced by at least 50% at 6 months. Of those patients, 65.4% reported continued pain reduction at 12 months post procedure. Initially, 67.1% and 62.7% of the Coolief and control participants reported severe arthritis symptoms, respectively. At 12 months, only 5.2% of Coolief patients reported similar levels of symptoms, versus 37....
Conclusion: The instrument proposed in the study exhibited content validity for most of its items and emerges as a practical strategy for the management of the daily interruption of sedation of critical patients.
Leading suicide theories and research in adults suggest that pain can exacerbate the suicidal risk of an individual. Although pain and suicidality (including suicidal ideation, behaviour, and death by suicide) both increase in prevalence during adolescence...
80 something yr old lady with left V1 phn. she failed all neuropathic agents you can think of. also failed capsaicin. i recently did supratrochlear and supraorbital block and got 100% relief for few days and still doing better but obviously block not lasting long. what do u guys do next? RF? pulsed RF? peripheral stim? any thoughts/experience appreciated
Robotic assistance may facilitate completion of minimally invasive hysterectomy, which is the standard of care for the treatment of early-stage endometrial cancer, in patients for whom conventional laparoscopy is challenging. The aim of this systematic review was to assess conversion to laparotomy and perioperative complications after laparoscopic (LH) and robotic hysterectomy (RH) in endometrial cancer patients with obesity.
This video demonstrates a laparoscopic assisted transverse abdominis plane (TAP) block as an alternative to the traditional anesthesiology-driven ultrasound-guided TAP block to reduce postoperative pain.
There are three general techniques for laparoscopic entry, all of which are considered safe and effective. These include the use of a veress needle, an optical trocar, and an open approach. Twenty-five percent of all injuries during laparoscopic surgery occur with initial entry. Therefore, a thoughtful approach to port placement is critical to ensure optimal performance and patient safety with entry. Certain patient factors that may increase the rate of injury or complicate entry include obesity, prior abdominal surgeries, large uterine size, and the small stature and short torso of the pediatric patient.
To investigate the safety and feasibility of robotic single-site for surgical resection of stage I to IV endometriosis in chronic pelvic pain patients.
To assess impact of abdominal ice packs on opioid use and pain control following laparoscopic hysterectomy.
To compare chronic pelvic pain and quality-of-life outcomes in women undergoing conservative or definitive surgery for pelvic pain.
To showcase a new approach to treatment of chronic pelvic pain after transobturator mesh placement.